5q- syndrome.
Boultwood J, Pellagatti A, Wainscoat JS.
Curr Pharm Des. 2012;18(22):3180-3. doi: 10.2174/1381612811209023180.
The 5q-syndrome.
Boultwood J, Lewis S, Wainscoat JS.
Blood. 1994 Nov 15;84(10):3253-60.
5q-syndrome in Japan.
Tasaka T, Tohyama K, Ohyashiki K, Ozawa K.
Int J Hematol. 2011 Jun;93(6):827-829. doi: 10.1007/s12185-011-0868-x. Epub 2011 May 13.
Recent Advances in the 5q- Syndrome.
Pellagatti A, Boultwood J.
Mediterr J Hematol Infect Dis. 2015 May 20;7(1):e2015037. doi: 10.4084/MJHID.2015.037. eCollection 2015.
Advances in the 5q- syndrome.
Boultwood J, Pellagatti A, McKenzie AN, Wainscoat JS.
Blood. 2010 Dec 23;116(26):5803-11. doi: 10.1182/blood-2010-04-273771. Epub 2010 Aug 23.
Molecular dissection of the 5q deletion in myelodysplastic syndrome.
Ebert BL.
Semin Oncol. 2011 Oct;38(5):621-6. doi: 10.1053/j.seminoncol.2011.04.010.
Closing in on the pathogenesis of the 5q- syndrome.
Post SM, Quintás-Cardama A.
Expert Rev Anticancer Ther. 2010 May;10(5):655-8. doi: 10.1586/era.10.44.
The 5q- syndrome.
Giagounidis AA, Germing U, Wainscoat JS, Boultwood J, Aul C.
Hematology. 2004 Aug;9(4):271-7. doi: 10.1080/10245330410001723824.
Biology and treatment of the 5q- syndrome.
Padron E, Komrokji R, List AF.
Expert Rev Hematol. 2011 Feb;4(1):61-9. doi: 10.1586/ehm.11.2.
5q deletion myelodysplastic syndrome.
Chari PS, Chander S, Sundareshan TS, Prasad S.
Indian J Pathol Microbiol. 2017 Apr-Jun;60(2):301-303. doi: 10.4103/0377-4929.208396.
